Measures for the Administration of Drug Recall

On:
In: Market Surveilliance, Medicine/medical devices
On October 26, the National medical product administration issued the newly revised Measures for the Administration of Drug Recall, which will come into force as of November 1. The new version of the Measures improves the handling measures for recalled drugs and clarifies the responsibilities of drug marketing license holders. The new version of the Measures has improved the holder’s requirements for the investigation and evaluation of drugs that may have quality problems or other potential safety hazards, refined the implementation procedures for the holder’s voluntary recall, and urged and guided the holder to actively recall drugs with quality problemsRead More →

Thank you for your interests/registration! For complete and full access to our platform, please contact us to subscribe as a paid-up member. The annual fee is ＄5,500 Best! Paolo yue Email: yuefeng7832@hotmail.com Cell: 008613501397114

Existing Users Log In
   
New User Registration
*Required field

Related posts:

  1. Measures for the administration of drug registration 2020
  2. Drug Administration Law
  3. Measures for Drug Distribution and Use
  4. Interim Measures of Subsidy Funds for Food and Drug Administration
  5. Interim Provisions on the administration of consumer goods recall
  6. Implementation of Drug Administration Law
  7. China issued specification for drug traceability code identification
  8. Implementation of GMP for veterinary drug production 2020
  9. Measures for drug patent disputes settlement
  10. Pharmacovigilance quality management specification